Skip to main content
Clinical Trials/EUCTR2019-000585-38-GB
EUCTR2019-000585-38-GB
Active, not recruiting
Phase 1

Chronic Endometritis and Recurrent Miscarriage - The CERM trial - The CERM Trial

niversity Hospitals Coventry and Warwickshire NHS Trust0 sites3,062 target enrollmentOctober 8, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospitals Coventry and Warwickshire NHS Trust
Enrollment
3062
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
niversity Hospitals Coventry and Warwickshire NHS Trust

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria \- screening
  • Age \=18 to \<42
  • Two or more consecutive first trimester intrauterine miscarriages (\=14 weeks gestation).
  • Women who agree to use barrier methods of contraception during the following cycles: biopsy preparation, screening\-biopsy, waiting for the results and during the intervention.
  • Inclusion criteria \- RCT
  • Women with \=5 CD138\+ cells/10mm2\.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 1500

Exclusion Criteria

  • Exclusion criteria – screening
  • Treatable cause(s) of RM for example:
  • oantiphospholipid antibody syndrome
  • othyroid disease
  • oparental karyotypical abnormalities.
  • Known sub\-septate uterus.
  • Poorly controlled diabetes (HbA1c \>48mmol/mol)
  • Allergy to doxycycline or its excipients.
  • Doxycycline contraindicated
  • Antibiotics in the current menstrual cycle

Outcomes

Primary Outcomes

Not specified

Similar Trials